“When Binh Nguyen, then a graduate student in biomedical engineering at the University of Toronto, was working in the renal engineering department of a local hospital, he was struck by what he felt was a suboptimal setup for dialysis treatment,” writes Jordana Dixon in “Health startup helps patients become more independent,” for the Globe and Mail on April 13, 2015.
eQOL Inc. is a University of Toronto and MaRS Innovation start-up company that participated in and graduated from the University of Toronto Early-Stage Technology (UTEST) program’s second cohort.
Taking these complications into consideration, Mr. Nguyen envisioned an all-encompassing lateral system that would optimize the process of in-home dialysis utilizing technology, but most importantly, improving patient experience.
SAULT STE. MARIE, February 13, 2015 — eQOL, a Sault Ste. Marie-based company working to enhance patient independence and a graduate of the second University of Toronto Early-Stage Technology (UTEST) incubator’s second cohort, has received $435,475 from the Ontario Government. David Orazietti, MPP for Sault Ste. Marie, made the announcement on February 13, 2015.
The funding, which includes $415,000 through the Northern Ontario Heritage Fund Corporation (NOHFC) and $20,475 to hire an intern under the Northern Ontario Internship Program also through NOHFC, will allow eQOL to complete clinical studies using their Dialysis Platform for Communication, Assistance and Training (DiCAT) product.
“With this support from our government, eQOL is able to use their innovative new technology in clinical studies – the first step towards commercializing the technology,” said Orazietti. “This software will not only enhance the quality of life for dialysis patients, but will also benefit our health care system and community as it streamlines processes and alleviates strain on hospital resources.”
DiCAT, a mobile technology solution for independent/home dialysis, aims to simplify and reduce the intimidation that patients experience with this self-care process. Its iPad and web-based applications provide enhanced connectivity, access to resources, and process management, which will promote a shift from in-centre care to in-home care. Successfully completing the clinical study and implementing DiCAT will allow patients who live far away from healthcare centres to receive care at home without having to relocate, which will have a great impact in northern regions.
Program’s second cohort includes eQOL, E-Twenty Development, Root2Crown, Treata Smart Solutions and TrendMD
TORONTO (May 14, 2013) — Five companies tackling pervasive healthcare challenges — such as assessing dental health, helping patients and medical personnel navigate hospitals with greater ease, staying current with medical literature, or creating digital tools to help care for the elderly or those with chronic health conditions — have been admitted to the University of Toronto Early Stage Technology (UTEST) program’s second cohort.
Two companies in UTEST’s second cohort, E-Twenty Development Inc. and Treata Smart Solutions Inc. are participating in Canada 3.0 at the Metro Convention Centre May 14 and 15, 2013, in Toronto.
This announcement was covered in PE Hub.
Each company will receive up to $25,000, incubation space in the MaRS Discovery District, mentoring and business strategy support to develop protectable intellectual property, launch their products and gain market traction. They are also eligible to become clients of MaRS Discovery District’s ICE or Healthcare practices.
UTEST seeks scalable, enterprise-focused software applications interested in building business-to-business customer bases — and preferably operational products with a short term to market. The program is co-directed by Kurtis Scissons (U of T IPO) and Dr. Lyssa Neel (MI).